Randomized Phase II Trial Comparing Site-Specific Treatment Based on Gene Expression Profiling With Carboplatin and Paclitaxel for Patients With Cancer of Unknown Primary SiteHidetoshi Hayashi, Kazuhiko Nakagawa, Hirofumi Mukai et al.|Journal of Clinical Oncology|2019Cited by 168
The OCT4 pseudogene POU5F1B is amplified and promotes an aggressive phenotype in gastric cancerHidetoshi Hayashi, Kazuto Nishio, Tokuzo Arao et al.|Oncogene|2013Cited by 143
Site-Specific and Targeted Therapy Based on Molecular Profiling by Next-Generation Sequencing for Cancer of Unknown Primary SiteHidetoshi Hayashi, Kazuhiko Nakagawa, Yuichi Takiguchi et al.|JAMA Oncology|2020Cited by 119
Melanoma Transition Is Frequently Accompanied by a Loss of Cytoglobin Expression in Melanocytes: A Novel Expression Site of CytoglobinYoshihiko Fujita, Kazuto Nishio|PLoS ONE|2014Cited by 26